MicroCal Appoints CEO and President
News Mar 21, 2006
MicroCal LLC has announced the appointment of Richard K. Brown as CEO and President. Rick will be succeeding William Gelb, who has been in the CEO role for the past six years.
Bill, who has served the company with excellence and dedication for over eleven years, will concurrently assume the Chairman role for the company.
Before joining Isis, Rick spent five years with Discovery Partners International (DPII). At DPII Rick was President of IRORI, one of their operating companies.
Prior to this, Rick spent 17 years in various capacities with companies involved in laboratory automation and analytical instruments used by life scientists in industry and academia.
Rick received his BS in Chemistry from Massachusetts State College in North Adams, MA and his Ph.D. in Chemistry from the University of Massachusetts, Amherst.
"I am particularly excited to be joining this well-regarded company at this time in their history. The number of new innovations and products we expect to announce as well the opportunity to further expand our reach to new customers and applications is extremely promising," said Rick during his recent introduction to the team members at MicroCal.
"I truly look forward to working with this group of talented and dedicated people to continue the impressive growth of MicroCal in its service to life-scientists around the globe."
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE
Faulty Gene Leads to Alcohol-Induced Heart FailureNews
A faulty gene interacts with alcohol to accelerate heart failure in susceptible patients, a study suggests. This dangerous interaction can occur even when only moderate amounts of alcohol have been consumed.READ MORE
Bicycle Therapeutics Expands Strategic Partnership with AstraZenecaNews
New programs added in respiratory and cardio-metabolic diseases.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018